Viridian Therapeutics Inc (VRDN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | VRDN | AMGN | BMY | VRTX | GILD |
| Company | Viridian Therapeutics Inc | Amgen Inc | Bristol-Myers Squibb Company | Vertex Pharmaceutic | Gilead Sciences Inc |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NYSE | NASDAQ | NASDAQ |
| Open | 19.45 | 289.90 | 58.30 | 446.64 | 90.00 |
| High | 19.45 | 289.90 | 58.30 | 446.64 | 90.00 |
| Low | 19.45 | 289.90 | 58.30 | 446.64 | 90.00 |
| Last | 19.73 | 289.33 | 57.97 | 454.12 | 90.01 |
| Change | +0.11 | -0.57 | -0.26 | +3.75 | +0.25 |
| % Change | +0.56% | -0.20% | -0.45% | +0.83% | +0.28% |
| Volume | 304 | 1,255 | 2,070 | 357 | 1,376 |
| 20-Day Average Volume | 1,130,675 | 2,842,698 | 12,042,104 | 1,294,818 | 7,242,464 |
| Previous Close | 19.62 | 289.90 | 58.23 | 450.37 | 89.76 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 22.21 | 306.06 | 56.24 | 477.68 | 90.94 |
| 20-Day Raw Stochastic | 0.00% | 27.22% | 70.01% | 2.19% | 30.58% |
| 20-Day Relative Strength | 39.60% | 36.50% | 60.87% | 39.84% | 54.11% |
| Weighted Alpha | -12.87 | +1.92 | +26.26 | +16.69 | +26.53 |
| Today's Opinion | 40% Buy | 40% Sell | 100% Buy | 24% Sell | 80% Buy |
| Previous Opinion | 40% Buy | 40% Sell | 100% Buy | 8% Sell | 80% Buy |
| Last Month's Opinion | 88% Buy | 8% Buy | 88% Buy | 24% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -3.43% since 11/15/24 | +2.22% since 11/15/24 | +3.70% since 11/15/24 | -4.09% since 11/15/24 | +1.81% since 11/15/24 |
| Low | 19.45 on 11/22/24 | 275.56 on 11/19/24 | 55.84 on 11/18/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 20.86 on 11/20/24 | 291.11 on 11/21/24 | 58.83 on 11/20/24 | 468.88 on 11/18/24 | 90.00 on 11/22/24 |
| 1-Month | |||||
| %Chg | -20.42% since 10/22/24 | -9.31% since 10/22/24 | +10.50% since 10/22/24 | -5.95% since 10/22/24 | +2.09% since 10/22/24 |
| Low | 19.45 on 11/22/24 | 275.56 on 11/19/24 | 51.81 on 10/28/24 | 445.00 on 11/21/24 | 86.08 on 11/19/24 |
| High | 27.20 on 11/12/24 | 328.25 on 11/08/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 3-Month | |||||
| %Chg | +26.79% since 08/22/24 | -10.67% since 08/22/24 | +22.43% since 08/22/24 | -6.93% since 08/22/24 | +18.58% since 08/22/24 |
| Low | 13.20 on 09/05/24 | 275.56 on 11/19/24 | 47.38 on 08/23/24 | 445.00 on 11/21/24 | 75.91 on 08/23/24 |
| High | 27.20 on 11/12/24 | 339.17 on 09/23/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| 6-Month | |||||
| %Chg | +53.15% since 05/22/24 | -6.31% since 05/22/24 | +37.69% since 05/22/24 | -0.20% since 05/22/24 | +32.74% since 05/22/24 |
| Low | 11.40 on 06/04/24 | 275.56 on 11/19/24 | 39.35 on 07/05/24 | 435.57 on 05/30/24 | 62.07 on 05/31/24 |
| High | 27.20 on 11/12/24 | 346.85 on 07/25/24 | 61.08 on 11/11/24 | 519.88 on 11/08/24 | 98.90 on 11/11/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 1,554,159 | 155,830,816 | 118,100,752 | 115,983,328 | 111,864,840 |
| Shares Outstanding, K | 79,213 | 537,533 | 2,028,177 | 257,529 | 1,246,266 |
| Annual Sales | 310,000 | 28,190,000,000 | 45,006,000,000 | 9,869,200,000 | 27,116,000,000 |
| Annual Net Income | -237,730,000 | 6,717,000,000 | 8,025,000,000 | 3,619,600,000 | 5,665,000,000 |
| Last Quarter Sales | 90,000 | 8,503,000,000 | 11,892,000,000 | 2,771,900,000 | 7,545,000,000 |
| Last Quarter Net Income | -76,690,000 | 2,830,000,000 | 1,211,000,000 | 1,045,400,000 | 1,253,000,000 |
| 60-Month Beta | 1.10 | 0.60 | 0.44 | 0.39 | 0.17 |
| Per-Share Information | |||||
| Most Recent Earnings | -1.15 on 11/12/24 | 5.58 on 10/30/24 | 1.80 on 10/31/24 | 4.38 on 11/04/24 | 2.02 on 11/06/24 |
| Latest Earnings Date | 11/11/24 | 10/30/24 | 10/31/24 | 11/04/24 | 11/06/24 |
| Most Recent Dividend | N/A | 2.250 on 11/18/24 | 0.600 on 10/04/24 | N/A | 0.770 on 09/13/24 |
| Next Ex-Dividends Date | N/A | 11/18/24 | 10/04/24 | N/A | 12/13/24 |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 14.98 | 49.47 | 0.00 | 20.01 |